$MRK News
Updates, advisories and surprises 6:01 p.m. Feb. 5, 2014 - MarketWatch
U.S. stocks fall; data stoke fears of slowdown 4:31 p.m. Feb. 5, 2014 - Anora Mahmudova
Stocks dip, end off day's lows; Twitter falls after hours: stock market live blog recap 4:27 p.m. Feb. 5, 2014 - blogs.marketwatch.com
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
The big Merck news centers on cancer-drug collaborations with other giants 11:02 a.m. Feb. 5, 2014 - blogs.marketwatch.com
U.S. stock futures turn up before market open 9:21 a.m. Feb. 5, 2014 - Barbara Kollmeyer
Twitter, the Nikkei pattern and why this might be your last chance to buy 8:28 a.m. Feb. 5, 2014 - blogs.marketwatch.com
Merck 4Q profit falls on weaker sales 8:21 a.m. Feb. 5, 2014 - MarketWatch.com
Merck fourth-quarter profit, revenue fall 7:14 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck sees 2014 adj. EPS of $3.35 to $3.53 7:05 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck Q4 sales fall to $11.32 bln from $11.74 bln 7:03 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck Q4 profit falls to $781 mln from $908 mln 7:03 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck Q4 EPS $0.26; Adj. EPS $0.88 7:03 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
The market in a minute: Bull vs. bear margin thins 9:17 a.m. Feb. 3, 2014 - The Trading Deck
‘Par’ earnings not good enough after 2013 stock run-up 10:13 p.m. Jan. 31, 2014 - Wallace Witkowski
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Saumya Vaishampayan
Technical damage inflicted, S&P’s trend turns lower 11:49 a.m. Jan. 27, 2014 - Michael Ashbaugh
Merck hits a new high as analyst sees opening for new cancer drug 11:16 a.m. Jan. 27, 2014 - blogs.marketwatch.com
Pfizer's Finally a Buy 8:15 a.m. Today - Barrons.com
Feb. 13 Premarket Briefing: 10 Things You Should Know 8:09 a.m. Today - TheStreet.com
Wall Street Breakfast: Must-Know News 6:32 a.m. Today - Seeking Alpha
WSJ: Bids for Merck's consumer business could top $10B 6:00 p.m. Feb. 12, 2014 - Seeking Alpha
Merck's Sale of Consumer Business Could Fetch $10 Billion 5:57 p.m. Feb. 12, 2014 - WSJ.com
5 Stocks Pulling The Drugs Industry Downward 12:02 p.m. Feb. 12, 2014 - TheStreet.com
Marginal Earnings Beat at Hospira in Q4 - Analyst Blog 11:05 a.m. Feb. 12, 2014 - Zacks.com
Gilead a Given for Hepatitis C Favorite 10:22 a.m. Feb. 12, 2014 - Barrons.com
Stock Market News for February 12, 2014 - Market News 10:06 a.m. Feb. 12, 2014 - Zacks.com
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers 3:13 a.m. Feb. 12, 2014 - Seeking Alpha
Merck & Co Inc (MRK): Today's Featured Health Care Winner 5:00 p.m. Feb. 11, 2014 - TheStreet.com
Stock Market News for February 11, 2014 - Market News 10:06 a.m. Feb. 11, 2014 - Zacks.com
Dow Today: Boeing (BA) Leads The Day Higher, Merck (MRK) Lags 10:00 a.m. Feb. 11, 2014 - TheStreet.com
Vanguard Health Care Fund's Top Five 5:25 p.m. Feb. 10, 2014 - GuruFocus.com
Companies Vie For .names In Internet Domain Expansion 4:04 p.m. Feb. 10, 2014 - Investors Business Daily
One Put, One Call Option To Know About For Merck & Co. 12:29 p.m. Feb. 10, 2014 - TheStreet.com
Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) 8:13 a.m. Feb. 10, 2014 - Benzinga.com
Is There Investment Upside In The Future Of Treating Diabetes? 8:01 a.m. Feb. 10, 2014 - Seeking Alpha
5 Not-So-Crazy Blue-Chip Spinoffs 5:39 a.m. Feb. 10, 2014 - InvestorPlace.com
FDA Panel to Weigh Painkillers' Cardiac Risk 4:32 p.m. Feb. 9, 2014 - WSJ.com
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
BIO-Europe Spring® Program in Turin Will Engage Executives in Provocative Topics Facing Drug Development Industry 9:00 a.m. Feb. 12, 2014 - BusinessWire - BZX
HTG Molecular Diagnostics Completes Initial Series E Preferred Stock Offering 7:02 a.m. Feb. 11, 2014 - Marketwire
Legal-Bay Lawsuit Settlement Funding Announce Settlements in Biomet Hip and NuvaRing Litigations 5:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes 8:30 a.m. Feb. 10, 2014 - BusinessWire - BZX
Absence of Blockbuster Drug Launches in 2014 Puts R&D Productivity at Risk 9:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Merck Announces Fourth-Quarter and Full-Year 2013 Financial Results 7:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Incyte Announces Clinical Trial Collaboration with Merck to Evaluate Combination of Two Novel Immunotherapies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Merck Enters Strategic Collaborations with Amgen, Incyte and Pfizer to Evaluate Novel Combination Anti-cancer Regimens with MK-3475 6:40 a.m. Feb. 5, 2014 - BusinessWire - BZX
Amgen And Merck Announce Collaboration To Evaluate Investigational Combination Treatment For Advanced Melanoma 6:15 a.m. Feb. 5, 2014 - PR Newswire - PRF
EffRx signs distribution agreements for Binosto® in Italy, Spain and Portugal 9:13 a.m. Feb. 4, 2014 - BusinessWire - BZX
Merck Announces Canadian Approval of GRASTEK® (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet) 8:30 a.m. Feb. 3, 2014 - BusinessWire - BZX
ALK's partner for North America, Merck, announces launch of GRASTEK(R) (GRAZAX(R)) in Canada 8:10 a.m. Feb. 3, 2014 - GlobeNewswire
ABLYNX ANNOUNCES WORLDWIDE CANCER IMMUNOTHERAPY DISCOVERY COLLABORATION AND LICENSING AGREEMENT WITH MERCK 1:08 a.m. Feb. 3, 2014 - GlobeNewswire
ABLYNX ANNOUNCES WORLDWIDE CANCER IMMUNOTHERAPY DISCOVERY COLLABORATION AND LICENSING AGREEMENT WITH MERCK 1:01 a.m. Feb. 3, 2014 - Thomson Reuters ONE
TechConnect, National Innovation, and SBIR/STTR Summit Announce Top Corporate Partners and Innovation Submission Deadline 10:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Critical Alerts For Advanced Micro Devices, Merck, Urban Outfitters, Peabody Energy, and TakeTwo Interactive Released By InvestorsObserver 9:31 a.m. Jan. 30, 2014 - PR Newswire - PRF
FDA Advisory Committee recommends approval of ragweed sublingual allergy immunotherapy tablet 3:02 p.m. Jan. 28, 2014 - GlobeNewswire
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Updates, advisories and surprises 6:01 p.m. Feb. 5, 2014 - MarketWatch
U.S. stocks fall; data stoke fears of slowdown 4:31 p.m. Feb. 5, 2014 - Anora Mahmudova
Stocks dip, end off day's lows; Twitter falls after hours: stock market live blog recap 4:27 p.m. Feb. 5, 2014 - blogs.marketwatch.com
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
The big Merck news centers on cancer-drug collaborations with other giants 11:02 a.m. Feb. 5, 2014 - blogs.marketwatch.com
U.S. stock futures turn up before market open 9:21 a.m. Feb. 5, 2014 - Barbara Kollmeyer
Twitter, the Nikkei pattern and why this might be your last chance to buy 8:28 a.m. Feb. 5, 2014 - blogs.marketwatch.com
Merck 4Q profit falls on weaker sales 8:21 a.m. Feb. 5, 2014 - MarketWatch.com
Merck fourth-quarter profit, revenue fall 7:14 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck sees 2014 adj. EPS of $3.35 to $3.53 7:05 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck Q4 sales fall to $11.32 bln from $11.74 bln 7:03 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck Q4 profit falls to $781 mln from $908 mln 7:03 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck Q4 EPS $0.26; Adj. EPS $0.88 7:03 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
The market in a minute: Bull vs. bear margin thins 9:17 a.m. Feb. 3, 2014 - The Trading Deck
‘Par’ earnings not good enough after 2013 stock run-up 10:13 p.m. Jan. 31, 2014 - Wallace Witkowski
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Saumya Vaishampayan
Technical damage inflicted, S&P’s trend turns lower 11:49 a.m. Jan. 27, 2014 - Michael Ashbaugh
Merck hits a new high as analyst sees opening for new cancer drug 11:16 a.m. Jan. 27, 2014 - blogs.marketwatch.com
Pfizer's Finally a Buy 8:15 a.m. Today - Barrons.com
Feb. 13 Premarket Briefing: 10 Things You Should Know 8:09 a.m. Today - TheStreet.com
Wall Street Breakfast: Must-Know News 6:32 a.m. Today - Seeking Alpha
WSJ: Bids for Merck's consumer business could top $10B 6:00 p.m. Feb. 12, 2014 - Seeking Alpha
Merck's Sale of Consumer Business Could Fetch $10 Billion 5:57 p.m. Feb. 12, 2014 - WSJ.com
5 Stocks Pulling The Drugs Industry Downward 12:02 p.m. Feb. 12, 2014 - TheStreet.com
Marginal Earnings Beat at Hospira in Q4 - Analyst Blog 11:05 a.m. Feb. 12, 2014 - Zacks.com
Gilead a Given for Hepatitis C Favorite 10:22 a.m. Feb. 12, 2014 - Barrons.com
Stock Market News for February 12, 2014 - Market News 10:06 a.m. Feb. 12, 2014 - Zacks.com
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers 3:13 a.m. Feb. 12, 2014 - Seeking Alpha
Merck & Co Inc (MRK): Today's Featured Health Care Winner 5:00 p.m. Feb. 11, 2014 - TheStreet.com
Stock Market News for February 11, 2014 - Market News 10:06 a.m. Feb. 11, 2014 - Zacks.com
Dow Today: Boeing (BA) Leads The Day Higher, Merck (MRK) Lags 10:00 a.m. Feb. 11, 2014 - TheStreet.com
Vanguard Health Care Fund's Top Five 5:25 p.m. Feb. 10, 2014 - GuruFocus.com
Companies Vie For .names In Internet Domain Expansion 4:04 p.m. Feb. 10, 2014 - Investors Business Daily
One Put, One Call Option To Know About For Merck & Co. 12:29 p.m. Feb. 10, 2014 - TheStreet.com
Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) 8:13 a.m. Feb. 10, 2014 - Benzinga.com
Is There Investment Upside In The Future Of Treating Diabetes? 8:01 a.m. Feb. 10, 2014 - Seeking Alpha
5 Not-So-Crazy Blue-Chip Spinoffs 5:39 a.m. Feb. 10, 2014 - InvestorPlace.com
FDA Panel to Weigh Painkillers' Cardiac Risk 4:32 p.m. Feb. 9, 2014 - WSJ.com
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
BIO-Europe Spring® Program in Turin Will Engage Executives in Provocative Topics Facing Drug Development Industry 9:00 a.m. Feb. 12, 2014 - BusinessWire - BZX
HTG Molecular Diagnostics Completes Initial Series E Preferred Stock Offering 7:02 a.m. Feb. 11, 2014 - Marketwire
Legal-Bay Lawsuit Settlement Funding Announce Settlements in Biomet Hip and NuvaRing Litigations 5:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes 8:30 a.m. Feb. 10, 2014 - BusinessWire - BZX
Absence of Blockbuster Drug Launches in 2014 Puts R&D Productivity at Risk 9:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Merck Announces Fourth-Quarter and Full-Year 2013 Financial Results 7:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Incyte Announces Clinical Trial Collaboration with Merck to Evaluate Combination of Two Novel Immunotherapies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Merck Enters Strategic Collaborations with Amgen, Incyte and Pfizer to Evaluate Novel Combination Anti-cancer Regimens with MK-3475 6:40 a.m. Feb. 5, 2014 - BusinessWire - BZX
Amgen And Merck Announce Collaboration To Evaluate Investigational Combination Treatment For Advanced Melanoma 6:15 a.m. Feb. 5, 2014 - PR Newswire - PRF
EffRx signs distribution agreements for Binosto® in Italy, Spain and Portugal 9:13 a.m. Feb. 4, 2014 - BusinessWire - BZX
Merck Announces Canadian Approval of GRASTEK® (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet) 8:30 a.m. Feb. 3, 2014 - BusinessWire - BZX
ALK's partner for North America, Merck, announces launch of GRASTEK(R) (GRAZAX(R)) in Canada 8:10 a.m. Feb. 3, 2014 - GlobeNewswire
ABLYNX ANNOUNCES WORLDWIDE CANCER IMMUNOTHERAPY DISCOVERY COLLABORATION AND LICENSING AGREEMENT WITH MERCK 1:08 a.m. Feb. 3, 2014 - GlobeNewswire
ABLYNX ANNOUNCES WORLDWIDE CANCER IMMUNOTHERAPY DISCOVERY COLLABORATION AND LICENSING AGREEMENT WITH MERCK 1:01 a.m. Feb. 3, 2014 - Thomson Reuters ONE
TechConnect, National Innovation, and SBIR/STTR Summit Announce Top Corporate Partners and Innovation Submission Deadline 10:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Critical Alerts For Advanced Micro Devices, Merck, Urban Outfitters, Peabody Energy, and TakeTwo Interactive Released By InvestorsObserver 9:31 a.m. Jan. 30, 2014 - PR Newswire - PRF
FDA Advisory Committee recommends approval of ragweed sublingual allergy immunotherapy tablet 3:02 p.m. Jan. 28, 2014 - GlobeNewswire
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
